Skip to main content
. 2020 Jul 20;9(3):LMT37. doi: 10.2217/lmt-2020-0014

Table 2. . Rate response.

Response Number of responses Percentage (95% CI)
CR 2 4% (0–8%)
PR 11 20% (9–30%)
SD 18 32% (20–44%)
PD 22 39% (26–52%)
NE 3 5% (0–11%)

CR: Complete response; NE: Not evaluable; PD: Disease progression; PR: Partial response; SD: Stable disease.